# BHV-7000 Acute Treatment of Bipolar Mania

> **NCT06419582** · PHASE2,PHASE3 · COMPLETED · sponsor: **Biohaven Therapeutics Ltd.** · enrollment: 274 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** BHV-7000
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06419582
- **Lead sponsor:** Biohaven Therapeutics Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-05-28
- **Primary completion:** 2025-01-15
- **Final completion:** 2025-01-30
- **Target enrollment:** 274 (ACTUAL)
- **Last updated:** 2025-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06419582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06419582, "BHV-7000 Acute Treatment of Bipolar Mania". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06419582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*